Montelukast sodium市場規模、佔有率及成長分析（依產品類型、劑型、藥物類別、應用、通路及地區）－2025-2032 年產業預測

2023 年全球Montelukast sodium市場規模為 4.582 億美元，預計將從 2024 年的 5.2739 億美元成長到 2032 年的 16.2455 億美元，預測期內（2025-2032 年）的複合年成長率為 15.1%。

全球Montelukast sodium市場正經歷顯著成長，原因是空氣污染加劇和老年人口成長導致氣喘和過敏性鼻炎病例增加，尤其是在日本、德國和義大利等地區。隨著醫療基礎設施的改善和Montelukast被納入治療指南，對該藥物的需求只會增加。製劑和聯合治療的技術創新進一步擴大了Montelukast的效用。此外，人工智慧、物聯網和區塊鏈等技術的進步正在透過加強藥物發現、確保妥善儲存和維護供應鏈的完整性來改變製藥業。在全球慢性呼吸系統疾病日益增多的背景下，這些趨勢使Montelukast sodium市場保持持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 案例研究

Montelukast sodium市場規模（依產品類型）

• 市場概覽
• 吸入器
  • 乾粉
  • 定量噴霧型
  • 緩霧
• 噴霧器

Montelukast sodium市場規模（以劑型）

• 市場概覽
• 藥片
• 口服溶液
• 其他

Montelukast sodium市場規模（依藥物類別）

• 市場概覽
• 消炎（藥）
• 支氣管擴張劑
• 聯合治療

Montelukast sodium市場規模（依應用）

• 市場概覽
• 氣喘
• 過敏性鼻炎
• 麻疹
• 其他用途

Montelukast sodium市場規模（依分銷管道）

• 市場概覽
• 醫院藥房
• 零售藥局
• 網路藥局

Montelukast sodium市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Teva Pharmaceuticals USA Inc.（US）
• Merck & Co. Inc.（US）
• Cipla Limited（India）
• Morepen Laboratories（India）
• Sanofi Aventis SA（France）
• SUN PHARMA（India）
• Intas Pharmaceuticals Ltd（India）
• Delmar Chemicals Inc.（Canada）
• SK Capital（Apotex Inc）（Canada）
• Sanyo Chemical Industries Ltd（Japan）

結論和建議

Global Montelukast Sodium Market size was valued at USD 458.2 million in 2023 and is poised to grow from USD 527.39 million in 2024 to USD 1624.55 million by 2032, growing at a CAGR of 15.1% during the forecast period (2025-2032).

The global montelukast sodium market is experiencing significant growth driven by a rise in asthma and allergic rhinitis cases, stemming from increasing air pollution and a growing elderly population, particularly in regions like Japan, Germany, and Italy. As healthcare infrastructure improves and montelukast is incorporated into treatment guidelines, demand for this medication continues to rise. Innovations in drug formulations and combination therapies are further expanding its usability. Additionally, advancements in technology, such as artificial intelligence, IoT, and blockchain, are transforming the pharmaceutical sector by enhancing drug discovery, ensuring proper storage, and maintaining supply chain integrity. These trends position the montelukast sodium market for sustained growth amid rising chronic respiratory issues globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Montelukast Sodium market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Montelukast Sodium Market Segments Analysis

Global Montelukast Sodium Market is segmented by Product Type, Dosage Form, Drug Class, Application, Distribution Channel and region. Based on Product Type, the market is segmented into Inhalers and Nebulizers. Based on Dosage Form, the market is segmented into Tablets, Oral solutions and Others. Based on Drug Class, the market is segmented into Anti-inflammatory, Bronchodilators and Combination Therapy. Based on Application, the market is segmented into Asthma, Allergic rhinitis, Urticaria and Other applications. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is being propelled by the rising incidence of respiratory disorders like asthma and allergic rhinitis, driven by various factors including air pollution, smoking, genetic factors, and shifts in lifestyle. As more people are diagnosed with chronic respiratory conditions linked to escalating air pollution, urbanization, climate change, and hereditary predispositions, there is a notable increase in demand for montelukast sodium. This growing recognition of the need for effective treatment options reflects the broader health trends and challenges contemporary societies face, ultimately contributing to the expansion of the montelukast sodium market on a global scale.

Restraints in the Global Montelukast Sodium Market

The global Montelukast Sodium market faces significant restraints due to the absence of patent protection, resulting in heightened competition among manufacturers. The presence of generic versions of Montelukast Sodium, often available at lower prices, adversely affects the sales of branded products. Additionally, the influx of inexpensive imported montelukast sodium further hampers the growth of domestic markets, making it challenging for local producers to compete effectively. This intense rivalry and price undercutting create a competitive landscape that restricts the potential expansion opportunities for established brands within the Montelukast Sodium sector, leading to a constrained market environment overall.

Market Trends of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is witnessing a significant trend driven by patent expirations, leading to a surge in generic formulations that provide equivalent therapeutic benefits at reduced prices. This shift is favored by patients, healthcare practitioners, and government health systems seeking cost-effective treatment options. As more pharmaceutical companies enter the market, increased competition is fostering innovation and accessibility in montelukast sodium products. Meanwhile, regulatory authorities continue to implement stringent approval processes for generics, ensuring safety and efficacy. This multifaceted landscape is reshaping the market dynamics, ultimately benefiting end-users while expanding the global reach of montelukast sodium.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Montelukast Sodium Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Inhalers
  • Dry Powder
  • Metered Dose
  • Soft Mist
• Nebulizers

Global Montelukast Sodium Market Size by Dosage Form & CAGR (2025-2032)

• Market Overview
• Tablets
• Oral solutions
• Others

Global Montelukast Sodium Market Size by Drug Class & CAGR (2025-2032)

• Market Overview
• Anti-inflammatory
• Bronchodilators
• Combination Therapy

Global Montelukast Sodium Market Size by Application & CAGR (2025-2032)

• Market Overview
• Asthma
• Allergic rhinitis
• Urticaria
• Other applications

Global Montelukast Sodium Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Global Montelukast Sodium Market Size & CAGR (2025-2032)

• North America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Teva Pharmaceuticals USA Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morepen Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Aventis SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SUN PHARMA (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delmar Chemicals Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Capital (Apotex Inc) (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanyo Chemical Industries Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations